Clinical Trial: A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772921) titled 'A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma' on Aug. 14.

Brief Summary: The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected.

The study is seeking participants who:

* Have a history of severe asthma for at least 12 months

* Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given sho...